Inhibition of cardiac inward-rectifier K+ current by terodiline

Citation
Se. Jones et al., Inhibition of cardiac inward-rectifier K+ current by terodiline, EUR J PHARM, 370(3), 1999, pp. 319-327
Citations number
47
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
370
Issue
3
Year of publication
1999
Pages
319 - 327
Database
ISI
SICI code
0014-2999(19990416)370:3<319:IOCIKC>2.0.ZU;2-D
Abstract
The antispasmodic agent terodiline has cardiotoxic effects that include QT lengthening. To determine whether inhibition of inwardly-rectifying K+ curr ent (I-K1) might be a factor in the cardiotoxicity, we measured I-K1 in gui nea pig ventricular myocytes. Terodiline reduced outward I-K1 with an IC50 of 7 mu M; maximal reduction was 60% with 100-300 mu M concentration. Inhib ition was independent of current direction, and persisted after removal of the drug. Terodiline (3-5 mu M) lengthened action potentials in guinea pig papillary muscles by ca. 10%, primarily by slowing phase 3 repolarization; higher concentrations abbreviated the plateau and markedly slowed late repo larization. Terodiline washout provoked an extra lengthening, consistent wi th persistent inhibition of I-K1 and rapid recovery of net inward plateau c urrent. The results suggest that inhibition of I-K1 is a likely factor in t he cardiotoxicity of the drug. (C) 1999 Elsevier Science B.V. All rights re served.